Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro,...
9 KB (671 words) - 19:42, 20 December 2023
a class of antiplatelet agents. Several GpIIb/IIIa inhibitors exist: abciximab (abcixifiban) (ReoPro) eptifibatide (Integrilin) tirofiban (Aggrastat)...
2 KB (175 words) - 18:45, 17 January 2024
fibrinogen. The gpIIb/IIIa receptor is a target of several drugs including abciximab, eptifibatide, and tirofiban. Once platelets are activated, granules secrete...
5 KB (500 words) - 06:24, 21 December 2023
(Persantine) Glycoprotein IIB/IIIA inhibitors (intravenous use only) Abciximab (ReoPro) Eptifibatide (Integrilin) Tirofiban (Aggrastat) Irreversible...
18 KB (1,752 words) - 06:09, 26 January 2024
Churchill Livingstone. pp. 241, for the examples infliximab, basiliximab, abciximab, daclizumab, palivusamab, gemtuzumab, alemtuzumab and rituximab, and mechanism...
47 KB (4,798 words) - 06:45, 26 May 2024
GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market. Eptifibatide...
11 KB (947 words) - 16:29, 11 May 2024
(INN) abatacept (USAN) Abasol (York Pharma) Abbokinase ABC Pack ABCD abciximab (INN) abecarnil (INN) Abecma abediterol (INN) Abegrin Abelcet (Sigma-Tau)...
2 KB (209 words) - 00:56, 19 April 2024
Developed the drug that is recommended for all cardiac angioplasties (abciximab) 1974 Created the first MRI image of a living organism Discovered the...
151 KB (13,763 words) - 00:18, 14 June 2024
form-factor for monoclonal antibodies designated for therapeutic use. The Fab abciximab, which inhibits blood clotting, works by disabling glycoprotein IIb/IIIa...
6 KB (691 words) - 07:30, 24 May 2024
Sakmar was acting-president from 2002.) Barry Coller, who invented the Abciximab, currently serves as the Vice President for Medical Affairs. In all, as...
37 KB (3,222 words) - 00:19, 15 April 2024